ArticleBreast care (Basel, Switzerland)2022

Long-Term Survival Outcomes of Patients with Small (≤1 cm) Node-Negative HER2-Positive Breast Cancer Not Treated with Adjuvant Anti-HER2-Targeted Therapy: A 10-Year Follow-Up Study.

Jenni S Liikanen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.